YMC Co., Ltd. has acquired all shares in ChromaCon AG (Zurich, Switzerland) and executed the transfer of 100% shares in the Company on April 1, 2019.
ChromaCon has a portfolio of proprietary continuous chromatography technologies and markets laboratory scale separation/purification systems utilizing these technologies globally. ChromaCon technology has pioneered twin-column purification that drastically increases productivity in both large (biopharmaceutical) and small (pharmaceutical) molecule manufacturing as well as significantly reduces operational cost.
YMC and ChromaCon have already built and maintained a strategic business alliance with YMC being an exclusive distributor of ChromaCon’s lab-scale systems in Japan and India. ChromaCon had also licensed technologies to YMC Process Technologies (“YPT”) (Devens MA, USA) for GMP production scale equipment. YMC completed its acquisition of YPT from LEWA-Nikkiso America December 2018. YPT develops and manufactures scale-up separation systems for the pharmaceutical manufacturing industry.
With ChromaCon joining the YMC Group, YMC has now a fully integrated organization (YMC, ChromaCon and YPT) leading the development and commercialization of continuous separation/purification systems for the biopharmaceutical and pharmaceutical industries from lab to production scale (GMP) manufacturing.
Moreover, the YMC Group provides a range of chromatography resins, columns and services which enable manufacturers to access a full complement of resources to facilitate the cost- effective production of next generation drugs.